Zhejiang Jingsheng Pharmaceutical Co., Ltd. Losartan Potassium Obtained European CEP Certificate
Zhejiang Jingsheng Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Zhejiang Tianyu Pharmaceutical Co., Ltd., received the European Pharmacopoeia Applicability Certificate for Losartan Potassium, issued by the European Agency for the Quality of Medicines. Certificate No.: R0-CEP 2021- 288-Rev 00, valid for five years from February 10, 2022.
Prev: The New Project Of Mojia Biotech (Guang An) Limited For Vb5 Will Begin To Produce in The First Half Of 2022.